SCHLUMBERGER LTD (SLB)       46.69  +1.64 (+3.64%)

46.69  +1.64 (+3.64%)

AN8068571086 - Common Stock - Premarket: 46.65 -0.04 (-0.09%)


Fundamental Rating

Overall SLB gets a fundamental rating of 6 out of 10. We evaluated SLB against 95 industry peers in the Energy Equipment & Services industry. SLB has a great profitability rating, but there are some minor concerns on its financial health. SLB shows excellent growth, but is valued quite expensive already.




Profitability

Profitability Rating


SLB has a Return On Assets of 4.98%. This is amongst the best returns in the industry. The industry average is -3.11%. SLB outperforms 81% of its industry peers.
SLB's Return On Equity of 13.63% is amongst the best of the industry. SLB does better than the industry average Return On Equity of 10.05%.

SLB has a Profit Margin of 8.84%. This is amongst the best returns in the industry. The industry average is -3.18%. SLB outperforms 85% of its industry peers.
The Piotroski-F score of SLB is 7.00. This is a strong score and indicates good health and profitability for SLB.
VS Industry

ROA (4.98%) VS Industry: 81% outperformed.

-800.00
1,345.08

ROE (13.63%) VS Industry: 63% outperformed.

0.38
54,700.00

Profit Margin (8.84%) VS Industry: 85% outperformed.

-773.95
220.86

Valuation

Valuation Rating


SLB's low PEG Ratio, which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The Forward Price/Earnings Ratio of 17.43 indicates a rather expensive current valuation of SLB.
When comparing the current price to the book value of SLB, we can conclude it is valued correctly. It is trading at 4.30 times its book value.
Compared to an average industry Enterprise Value to EBITDA ratio of 11.88, SLB is valued in line with its industry peers.

With a Price/Earnings Ratio of 33.11, SLB can be considered very expensive at the moment.
SLB's Price/Earning Ratio is slightly more expensive than the industry average, which is at 28.02.
Compared to an average industry price book ratio of 1.55, SLB is valued more expensive than its industry peers. 87% of the companies listed in the same industry are valued cheaper.
VS Industry

Price/Earnings (33.11) VS Industry: 34% outperformed.

2,702.00
0.21

Price/Book (4.3) VS Industry: 13% outperformed.

828.53
0.02

Enterprise Value/ EBITDA (13.13) VS Industry: 45% outperformed.

471.01
0.74

Growth

Growth Rating


SLB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 120.31%, which is quite impressive.
Based on estimates for the next 5 years, SLB will show a very strong growth in Earnings Per Share. The EPS will grow by 33.18% on average per year.
The EPS growth is accelerating: in the next 5 years the growth will be better than in the last years.
Looking at the last year, SLB shows a quite strong growth in Revenue. The Revenue has grown by 10.76% in the last year.

The Revenue is expected to grow by 12.14% on average over the next 5 years. This is quite good.
When comparing the Revenue growth rate of the last 5 years to the growth rate of the upcoming 5 years, we see that the growth is accelerating.
SLB shows a small growth in Earnings Per Share. Measured over the last 5 years, the EPS has been growing by 2.17% yearly.
Measured over the past 5 years, SLB shows a decrease in Revenue. The Revenue has been decreasing by -3.79% on average per year.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPS2.17% -7.74% 120.31% 47.75% 44.67% 35.56% 33.18%
Revenue-3.79% -11.26% 10.76% 14.82% 14.86% 12.76% 12.14%

Health

Health Rating


When comparing the Altman-Z score to an average industry score of 1.38, SLB is in better financial health than the average industry peer.
SLB has a good Piotroski-F score of 7.00. This indicates a good health and good profitability for SLB.
SLB has a Current Ratio of 1.24. This is a normal value and indicates that SLB is financially healthy and should not expect problems in meeting its short term obligations.
SLB has an Altman-Z score of 2.47. This is not the best score and indicates that SLB is in the grey zone with still only limited risk for bankruptcy at the moment.

When comparing the Current Ratio of SLB to the average industry Current Ratio of 1.89, SLB is less able to pay its short term obligations than its industry peers. 80% of its industry peers have a better Current Ratio.
SLB has a Quick Ratio of 1.24. This is a bad value and indicates that SLB is not financially healthy enough and could expect problems in meeting its short term obligations.
Compared to an average industry Quick Ratio of 1.48, SLB is worse placed to pay its short term obligations than its industry peers. 88% of its industry peers have a better Quick Ratio.
When comparing the Debt to Equity Ratio of SLB to the average industry Debt to Equity Ratio of 0.28, SLB required more debt to finance its operations than its industry peers.
VS Industry

Debt/Equity (0.86) VS Industry: 27% outperformed.

544.09
-141.23

Quick Ratio (0.89) VS Industry: 12% outperformed.

0.18
8.19

Current Ratio (1.24) VS Industry: 20% outperformed.

0.18
10.20

Altman-Z (2.47) VS Industry: 73% outperformed.

-574.72
38.68

Dividend

Dividend Rating


33.46% of the earnings are spent on dividend by SLB. This is a low number and sustainable payout ratio.
SLB has been paying a dividend for at least 10 years, so it has a reliable track record.
With a Yearly Dividend Yield of 1.63%, SLB has a reasonable but not impressive dividend return.

Compared to an average industry Dividend Yield of 2.04, SLB is paying slightly less dividend.
Compared to the average S&P500 Dividend Yield of 2.18, SLB is paying slightly less dividend.
The dividend of SLB decreases each year by -41.52%.
VS Industry

Dividend Yield (1.63%) VS Industry: 39% outperformed.

0.16
11.97
SLB Daily chart

SCHLUMBERGER LTD46.69

NYSE:SLB (5/26/2022, 7:22:22 PM)+1.64 (+3.64%)

Premarket: 46.65 -0.04 (-0.09%)

Chartmill FA Rating
GICS Sector Energy
GICS IndustryGroup Energy
GICS Industry Energy Equipment & Services
Earnings (Last) 04-22 2022-04-22/bmo Earnings (Next) 07-21 2022-07-21
Ins Owners 0.19% Inst Owners 78.42%
Market Cap 65.99B Analysts 82.29
Valuation
PE 33.11 Fwd PE 17.43
PEG (NY) 0.69 PEG (5Y) 15.29
P/S 2.79 P/B 4.3
EV/EBITDA 13.13
Profitability
ROA 4.98% ROE 13.63%
PM 8.84 Asset Turnover 0.56
Growth
EPS 1Y 120.31% EPS 3Y -7.74%
EPS 5Y 2.17% EPS growth Q2Q 61.9%
EPS Next Y 47.75% EPS Next 2Y 44.67%
EPS Next 3Y 35.56% EPS Next 5Y 33.18%
Revenue growth 1Y 10.76% Revenue growth 3Y -11.26%
Revenue growth 5Y -3.79% Revenue growth Q2Q 14.15%
Revenue Next Year 14.82% Revenue Next 2Y 14.86%
Revenue Next 3Y 12.76% Revenue Next 5Y 12.14%
Health
Current Ratio 1.24 Quick Ratio 0.89
Altman-Z 2.47 F-Score 7
Debt/Equity 0.86
Dividend
Dividend Yield 1.63% Dividend Growth -41.52%
DP 33.46% Ex-Date 05-31 2022-05-31 (0.175)

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Growth Stock Screener

Find more growth stocks the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA